Furthermore, downregulation of SRC-1 expression inhibited the growth of prostate cancer cells and decreased the transcriptional activity of prostate-specific antigen (PSA), an AR target gene [79] (Fig. 5). The gene discussed is SRC; the disease is prostate carcinoma.